Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Jazz Venture Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Jazz Venture Partners

Jazz Venture Partners

Operating

JAZZ Venture Partners: A tech-focused VC firm investing in breakthroughs to enhance human performance.

Location
San Francisco, CA, US
Founded
2015
Firm
Compare
Portfolio
Fundraising
Employees
Website

Investments

Reken
Reken

Total Raised

$10M

Rounds

1

Seed$10MJanuary 2024
Tomato AI
Tomato AI

Total Raised

$10M

Rounds

2

Seed$10MSeptember 2023
Robust.AI
Robust.AI

Total Raised

$42.5M

Rounds

3

Series A$20MApril 2023
Zus Health
Zus Health

Total Raised

$74M

Rounds

2

Series A$40MMarch 2023
Cadence Neuroscience
Cadence Neuroscience

Total Raised

$41M

Rounds

3

Series B$26MFebruary 2023
Colossal Biosciences
Colossal Biosciences

Total Raised

$235.5M

Rounds

5

Series B$150MJanuary 2023
Series A$60MMarch 2022
Enveda Biosciences
Enveda Biosciences

Total Raised

$174.9M

Rounds

7

Series B$55MDecember 2022
Cabservices24x7
Cabservices24x7

Total Raised

$30M

Rounds

1

Series A$30MSeptember 2022
Foresight Mental Health
Foresight Mental Health

Rounds

7

Series CJune 2022
JobGet
JobGet

Total Raised

$54.4M

Rounds

5

Series B$40MJune 2022
Swing Therapeutics
Swing Therapeutics

Total Raised

$19.3M

Rounds

2

Series A$10.3MJune 2022
Seed$9MAugust 2021
Klowen Braces
Klowen Braces

Total Raised

$16.5M

Rounds

3

Series A$10.5MMay 2022
Augment AI
Augment AI

Total Raised

$3.5M

Rounds

1

Seed$3.5MJanuary 2022
Yumi
Yumi

Total Raised

$99.1M

Rounds

9

Series B$67MDecember 2021
Pear Therapeutics
Pear Therapeutics
Public

Total Raised

$409M

Rounds

9

Post Ipo Equity$125MDecember 2021
Sounding Board
Sounding Board

Total Raised

$45M

Rounds

5

Series B$30MDecember 2021
AppliedVR
AppliedVR

Total Raised

$71M

Rounds

3

Series B$36MNovember 2021
Magnus Medical
Magnus Medical

Total Raised

$25M

Rounds

1

Series A$25MOctober 2021
NextStep
NextStep

Total Raised

$15.6M

Rounds

5

Series A$3.3MOctober 2021
HumanCo
HumanCo

Total Raised

$35M

Rounds

4

Convertible Note$35MSeptember 2021
Blue Note Therapeutics
Blue Note Therapeutics

Total Raised

$46.9M

Rounds

3

Series A$5.2MSeptember 2021
Woebot Health
Woebot Health

Total Raised

$123.3M

Rounds

4

Series B$90MJuly 2021
Ten Spot
Ten Spot

Total Raised

$9.5M

Rounds

4

Series A$5MJuly 2021